The futility of adverse drug event reporting systems for monitoring known safety issues: A case study of myocardial infarction with rofecoxib and other drugs

被引：2
|
作者：
Haguinet, Francois [1 ]
Bate, Andrew [2 ,3 ]
Stegmann, Jens-Ulrich [1 ]
机构：
[1] GSK, Global Safety, Wavre, Belgium
[2] GSK, Global Safety, Brentford, England
[3] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷 / 01期
关键词：
labeled adverse events; myocardial infarction; pharmacovigilance; real-world data; rofecoxib; Sentinel; spontaneous reporting system; FOOD;
D O I：
10.1002/pds.5719
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：5
相关论文
共 15 条
  • [1] Comparing Time to Adverse Drug Reaction Signals in a Spontaneous Reporting Database and a Claims Database: A Case Study of Rofecoxib-Induced Myocardial Infarction and Rosiglitazone-Induced Heart Failure Signals in Australia
    Izyan A.Wahab
    Nicole L. Pratt
    Lisa M. Kalisch
    Elizabeth E. Roughead
    Drug Safety, 2014, 37 : 53 - 64
  • [2] Comparing Time to Adverse Drug Reaction Signals in a Spontaneous Reporting Database and a Claims Database: A Case Study of Rofecoxib-Induced Myocardial Infarction and Rosiglitazone-Induced Heart Failure Signals in Australia
    Wahab, Izyan A.
    Pratt, Nicole L.
    Kalisch, Lisa M.
    Roughead, Elizabeth E.
    DRUG SAFETY, 2014, 37 (01) : 53 - 64
  • [3] Analysis of individual case safety reports of drug-induced anaphylaxis to the Korea Adverse Event Reporting System
    Cho, Min Kyoung
    Moon, Mira
    Kim, Hyun Hwa
    Kang, Dong Yoon
    Lee, Ju-Yeun
    Cho, Sang-Heon
    Kang, Hye-Ryun
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2020, 8 (01): : 30 - 35
  • [4] Association of anxiolytic drugs with Torsade de Pointes: a pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System
    Ali, Zahid
    Ismail, Mohammad
    Rehman, Inayat Ur
    Goh, Khang Wen
    Razi, Pakhrur
    Ming, Long Chiau
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [5] Clinical adverse events to letairis: a real-world drug safety study based on FDA Adverse Event Reporting System (FAERS)
    Bi, Yu-Ting
    Dong, Bo
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [6] Post-Marketing Safety of Temozolomide: A Pharmacovigilance Study Based on the Food and Drug Administration Adverse Event Reporting System
    Lin, Yuhao
    Deng, Muling
    Xu, Siqi
    Chen, Chuanben
    Ding, Jianming
    ONCOLOGY, 2025,
  • [7] Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database
    Sato, Kenichiro
    Mano, Tatsuo
    Iwata, Atsushi
    Toda, Tatsushi
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 (03) : 1333 - 1344
  • [8] A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data
    Yan, Yu
    Wang, Ling
    Yuan, Yanling
    Xu, Jiayue
    Chen, Yuxian
    Wu, Bin
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (06) : 771 - 776
  • [9] Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
    Zhou, Zhi-Xuan
    Yin, Xue-Dong
    Zhang, Yu
    Shao, Qi-Hui
    Mao, Xin-Yu
    Hu, Wen-Juan
    Shen, Yun-Lin
    Zhao, Bin
    Li, Zhi-Ling
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
    He, Menglin
    Yang, Taoran
    Zhou, Jian
    Wang, Rurong
    Li, Xuehan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12